Researchers identify multiple molecules that shut down SARS-Cov-2 polymerase reaction

(Columbia University School of Engineering and Applied Science) Researchers at Columbia Engineering and the University of Wisconsin-Madison have identified a library of molecules that shut down the SARS-CoV-2 polymerase reaction, a key step that establishes the potential of these molecules as lead compounds to be further modified for the development of COVID-19 therapeutics. Five of these molecules are already FDA-approved for use in the treatment of other viral infections including HIV/AIDS, cytomegalovirus, and hepatitis B.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news